Adams Primary Care | |
620 Main St Suite A Adams NE 68301-8277 | |
(402) 988-2188 | |
(402) 988-2203 |
Full Name | Adams Primary Care |
---|---|
Speciality | Clinic/Center |
Location | 620 Main St, Adams, Nebraska |
Authorized Official Name and Position | Mary Jane Kent (CEO) |
Authorized Official Contact | 4023353361 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Adams Primary Care Po Box 538 Tecumseh NE 68450-0538 Ph: (402) 335-2811 | Adams Primary Care 620 Main St Suite A Adams NE 68301-8277 Ph: (402) 988-2188 |
NPI Number | 1003027442 |
---|---|
Provider Enumeration Date | 05/25/2007 |
Last Update Date | 01/19/2022 |
Medicare PECOS PAC ID | 4688583644 |
---|---|
Medicare Enrollment ID | O20070829000811 |
News Archive
A new study shows that an implantable delivery system for a widely used medication to treat a blinding eye disease has enabled some patients to go 15 months in between treatments. This represents a vast improvement over the typical regimen of nearly monthly eye injections.
The Department of Veterans Affairs is releasing for public comment a draft of its strategic report to address key issues facing women Veterans. The plan outlines steps for improvements to care and services for women Veterans that are sustainable, accountable and a part of the department's culture and operations.
Alabama is the latest in a growing list of states passing bans on abortion in an attempt to get the Supreme Court to weaken or overturn Roe v. Wade, the 1973 ruling that legalized abortion nationwide. Unlike most of the other state laws that have passed this year, however, the Alabama law would completely ban abortion except when the woman's life was in danger from the pregnancy.
Researchers from the universities of Calgary and Cambridge, UK, have discovered that a mutation in a gene necessary for the metabolism of folic acid not only impacts immediate offspring but can also have detrimental health effects, such as spina bifida and heart abnormalities, on subsequent generations.
Everyone in England aged 55 to 59 will be invited for a new test which could dramatically cut their chances of developing bowel cancer. This new test could save an extra 3,000 lives every year after the UK National Screening Committee gave the nod for it to be added to the NHS programme. The test known as Flexible sigmoidoscopy (FS) differs to the current faecal occult blood (FOB) test, which relies on people sending off stool samples.
› Verified 5 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1003027442 | NPI | - | NPPES |
10025542000 | Medicaid | NE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
261QR1300X | Clinic/center - Rural Health | (* (Not Available)) | Primary |
News Archive
A new study shows that an implantable delivery system for a widely used medication to treat a blinding eye disease has enabled some patients to go 15 months in between treatments. This represents a vast improvement over the typical regimen of nearly monthly eye injections.
The Department of Veterans Affairs is releasing for public comment a draft of its strategic report to address key issues facing women Veterans. The plan outlines steps for improvements to care and services for women Veterans that are sustainable, accountable and a part of the department's culture and operations.
Alabama is the latest in a growing list of states passing bans on abortion in an attempt to get the Supreme Court to weaken or overturn Roe v. Wade, the 1973 ruling that legalized abortion nationwide. Unlike most of the other state laws that have passed this year, however, the Alabama law would completely ban abortion except when the woman's life was in danger from the pregnancy.
Researchers from the universities of Calgary and Cambridge, UK, have discovered that a mutation in a gene necessary for the metabolism of folic acid not only impacts immediate offspring but can also have detrimental health effects, such as spina bifida and heart abnormalities, on subsequent generations.
Everyone in England aged 55 to 59 will be invited for a new test which could dramatically cut their chances of developing bowel cancer. This new test could save an extra 3,000 lives every year after the UK National Screening Committee gave the nod for it to be added to the NHS programme. The test known as Flexible sigmoidoscopy (FS) differs to the current faecal occult blood (FOB) test, which relies on people sending off stool samples.
› Verified 5 days ago